Primary Graft Failure after Heart Transplantation
Primary graft failure (PGF) is a devastating complication that occurs in the immediate postoperative period following heart transplantation. It manifests as severe ventricular dysfunction of the donor graft and carries significant mortality and morbidity. In the last decade, advances in pharmacologi...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151502/ |
id |
pubmed-3151502 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-31515022011-08-11 Primary Graft Failure after Heart Transplantation Iyer, Arjun Kumarasinghe, Gayathri Hicks, Mark Watson, Alasdair Gao, Ling Doyle, Aoife Keogh, Anne Kotlyar, Eugene Hayward, Christopher Dhital, Kumud Granger, Emily Jansz, Paul Pye, Roger Spratt, Phillip Macdonald, Peter Simon Review Article Primary graft failure (PGF) is a devastating complication that occurs in the immediate postoperative period following heart transplantation. It manifests as severe ventricular dysfunction of the donor graft and carries significant mortality and morbidity. In the last decade, advances in pharmacological treatment and mechanical circulatory support have improved the outlook for heart transplant recipients who develop this complication. Despite these advances in treatment, PGF is still the leading cause of death in the first 30 days after transplantation. In today's climate of significant organ shortages and growing waiting lists, transplant units worldwide have increasingly utilised “marginal donors” to try and bridge the gap between “supply and demand.” One of the costs of this strategy has been an increased incidence of PGF. As the threat of PGF increases, the challenges of predicting and preventing its occurrence, as well as the identification of more effective treatment modalities, are vital areas of active research and development. Hindawi Publishing Corporation 2011 2011-08-01 /pmc/articles/PMC3151502/ /pubmed/21837269 http://dx.doi.org/10.1155/2011/175768 Text en Copyright © 2011 Arjun Iyer et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Iyer, Arjun Kumarasinghe, Gayathri Hicks, Mark Watson, Alasdair Gao, Ling Doyle, Aoife Keogh, Anne Kotlyar, Eugene Hayward, Christopher Dhital, Kumud Granger, Emily Jansz, Paul Pye, Roger Spratt, Phillip Macdonald, Peter Simon |
spellingShingle |
Iyer, Arjun Kumarasinghe, Gayathri Hicks, Mark Watson, Alasdair Gao, Ling Doyle, Aoife Keogh, Anne Kotlyar, Eugene Hayward, Christopher Dhital, Kumud Granger, Emily Jansz, Paul Pye, Roger Spratt, Phillip Macdonald, Peter Simon Primary Graft Failure after Heart Transplantation |
author_facet |
Iyer, Arjun Kumarasinghe, Gayathri Hicks, Mark Watson, Alasdair Gao, Ling Doyle, Aoife Keogh, Anne Kotlyar, Eugene Hayward, Christopher Dhital, Kumud Granger, Emily Jansz, Paul Pye, Roger Spratt, Phillip Macdonald, Peter Simon |
author_sort |
Iyer, Arjun |
title |
Primary Graft Failure after Heart Transplantation |
title_short |
Primary Graft Failure after Heart Transplantation |
title_full |
Primary Graft Failure after Heart Transplantation |
title_fullStr |
Primary Graft Failure after Heart Transplantation |
title_full_unstemmed |
Primary Graft Failure after Heart Transplantation |
title_sort |
primary graft failure after heart transplantation |
description |
Primary graft failure (PGF) is a devastating complication that occurs in the immediate postoperative period following heart transplantation. It manifests as severe ventricular dysfunction of the donor graft and carries significant mortality and morbidity. In the last decade, advances in pharmacological treatment and mechanical circulatory support have improved the outlook for heart transplant recipients who develop this complication. Despite these advances in treatment, PGF is still the leading cause of death in the first 30 days after transplantation. In today's climate of significant organ shortages and growing waiting lists, transplant units worldwide have increasingly utilised “marginal donors” to try and bridge the gap between “supply and demand.” One of the costs of this strategy has been an increased incidence of PGF. As the threat of PGF increases, the challenges of predicting and preventing its occurrence, as well as the identification of more effective treatment modalities, are vital areas of active research and development. |
publisher |
Hindawi Publishing Corporation |
publishDate |
2011 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151502/ |
_version_ |
1611469424271818752 |